Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & Administrative
Others
Ratios

AC Immune (ACIU) Depreciation & Amortization - Total (2016 - 2025)

Historic Depreciation & Amortization - Total for AC Immune (ACIU) over the last 3 years, with Q4 2016 value amounting to -$278006.8.

  • AC Immune's Depreciation & Amortization - Total rose 414.31% to -$278006.8 in Q4 2016 from the same period last year, while for Sep 2017 it was -$278006.8, marking a year-over-year increase of 414.31%. This contributed to the annual value of -$2.1 million for FY2021, which is 2810.43% down from last year.
  • According to the latest figures from Q4 2016, AC Immune's Depreciation & Amortization - Total is -$278006.8, which was up 414.31% from -$290022.7 recorded in Q4 2015.
  • Over the past 5 years, AC Immune's Depreciation & Amortization - Total peaked at -$278006.8 during Q4 2016, and registered a low of -$309203.7 during Q4 2014.
  • Its 3-year average for Depreciation & Amortization - Total is -$292411.1, with a median of -$290022.7 in 2015.
  • In the last 5 years, AC Immune's Depreciation & Amortization - Total soared by 620.34% in 2015 and then surged by 414.31% in 2016.
  • AC Immune's Depreciation & Amortization - Total (Quarter) stood at -$309203.7 in 2014, then rose by 6.2% to -$290022.7 in 2015, then grew by 4.14% to -$278006.8 in 2016.
  • Its last three reported values are -$278006.8 in Q4 2016, -$290022.7 for Q4 2015, and -$309203.7 during Q4 2014.